Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.

Ghany R, Palacio A, Dawkins E, Chen G, McCarter D, Forbes E, Chung B, Tamariz L

Open source

DOI
10.1016/j.dsx.2021.02.022
Published
2021 Mar-Apr
Container
Diabetes & metabolic syndrome
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.dsx.2021.02.022,
  title = {Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.},
  author = {Ghany R and Palacio A and Dawkins E and Chen G and McCarter D and Forbes E and Chung B and Tamariz L},
  year = {2021},
  journal = {Diabetes \& metabolic syndrome},
  doi = {10.1016/j.dsx.2021.02.022},
  url = {https://doi.org/10.1016/j.dsx.2021.02.022}
}

RIS

TY  - JOUR
TI  - Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
AU  - Ghany R
AU  - Palacio A
AU  - Dawkins E
AU  - Chen G
AU  - McCarter D
AU  - Forbes E
AU  - Chung B
AU  - Tamariz L
PY  - 2021
JO  - Diabetes & metabolic syndrome
DO  - 10.1016/j.dsx.2021.02.022
UR  - https://doi.org/10.1016/j.dsx.2021.02.022
ER  - 

APA

R, G., A, P., E, D., G, C., D, M., E, F., B, C., & L, T. (2021). Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.. Diabetes & metabolic syndrome. https://doi.org/10.1016/j.dsx.2021.02.022

Source records